Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT

Chalandon, Y. orcid.org/0000-0001-9341-8104, Sbianchi, G., Gras, L. et al. (22 more authors) (2023) Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT. American Journal of Hematology, 98 (1). pp. 112-121. ISSN 0361-8609

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2022 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Keywords: Humans; Imatinib Mesylate; Protein Kinase Inhibitors; Retrospective Studies; Tyrosine Protein Kinase Inhibitors; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Hematopoietic Stem Cell Transplantation
Dates:
  • Published: January 2023
  • Published (online): 31 October 2022
  • Accepted: 12 October 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 09 Jun 2023 11:37
Last Modified: 09 Jun 2023 11:37
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1002/ajh.26764
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics